What are the large-scale culture techniques for iPS cells and their applications in cardiac tissue engineering in the field of regenerative medicine/cell engineering?
In this seminar, we will hear a lecture from Dr. Katsuhisa Matsuura on the basic concepts of iPS cells, as well as the large-scale culture technology of iPS cells he is working on and its application research in cardiac tissue engineering. ◎Title "Development of Large-Scale Culture Technology for iPS Cells and Its Application in Cardiac Tissue Engineering" ◎Speaker Dr. Katsuhisa Matsuura (Tokyo Women's Medical University, Advanced Research Institute for Life Science) ◎Date and Time July 11, 2022 (Monday) 10:00 AM to August 8, 2022 (Monday) 1:00 PM ◎Target Audience Individuals involved in research, development, manufacturing, planning, or sales in the field of regenerative medicine/cell engineering *To apply for viewing this seminar, please proceed to the application form via the link below.
Inquire About This Product
basic information
【Cell Preservation Solutions from the Far East】 ・CP-1 High Grade ・CP-5E ・Cell Transport and Storage Solution (for refrigerated and room temperature storage) *If you would like a sample, please apply through the inquiry form. Note that sample provision is available for new inquiries only. If you have any requests or questions, please feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please see the seminar registration page. If you have any questions, please feel free to contact us.
catalog（5）
Download All Catalogs
Company information
Since its founding, Kyokuto Pharmaceutical Industrial has supported the medical field in protecting human "health" through the manufacture and sale of bacterial culture media, media and reagents for bacterial testing, and clinical testing reagents and equipment. Looking to the future, we are now adding the perspective of "preventive medicine testing" to our traditional focus on "diagnostic and therapeutic testing." Based on the technologies and know-how accumulated in clinical testing, we are also venturing into the fields of cell culture-related products that serve as raw materials for advanced medicine and pharmaceuticals, as well as food and environmental testing, embarking on new challenges.
